Using Epidemiologic Methods to Advance Comparative Effectiveness Research
Track
:
Track 13: Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)
Program Code:
140
Date:
Monday, June 24, 2013
Time:
2:30 PM to 4:00 PM
EST
Location:
151B
CHAIR
:
Nancy A. Dreyer, PhD,MPH,FISPE (SCHNON), Senior Vice President, Global Chief of Scientific Affairs, Quintiles Outcome, United States
Nancy A. Dreyer is Global Chief of Scientific Affairs and Sr Vice President at Quintiles Outcome. Dreyer specializes in the conduct of observational research on comparative effectiveness and safety of medicines and medical devices, and is active in methods development.
SPEAKER
(S):
Nancy A. Dreyer, PhD,MPH,FISPE (SPKNON), Senior Vice President, Global Chief of Scientific Affairs, Quintiles Outcome, United States
Nancy A. Dreyer is Global Chief of Scientific Affairs and Sr Vice President at Quintiles Outcome. Dreyer specializes in the conduct of observational research on comparative effectiveness and safety of medicines and medical devices, and is active in methods development.
Kenneth J. Rothman, DrPH,FISPE (SPKNON), Distinguished Fellow, RTI Health Solutions, United States
Dr. Rothman's career focus has been the conceptual issues underlying the design and analysis of epidemiologic studies. He has authored both introductory and advanced textbooks for epidemiologists. In addition to his RTI position he is a professor at the Boston University School of Public Health.
Hans-Georg Eichler, MD,MSc (SPKAGY), Senior Medical Officer, European Medicines Agency, European Union, United Kingdom
Before becoming Senior Medical Officer, Dr Eichler was professor and chair of clinical pharmacology and vice-rector at the Medical University of Vienna. Other positions held include President of the Vienna School of Clinical Research. His industry experience includes UK Ciba-Geigy and US Merck & Co
Description
The strengths and limitations of observational studies of comparative effectiveness research will be presented, along with a discussion of epidemiologic methods, resources, and a validated scale for assessing observational study quality.